Drugs & Medical Devices
Get ready for the next wave of pharmaceutical litigation with HarrisMartin's Drugs & Medical Devices. This reporter will keep you one step ahead of drug and medical device litigation with in-depth investigations, guest commentaries and objective courtroom coverage on today's and tomorrow's hottest drugs and supplements.
SEARCH THE ARCHIVES
A federal appeals court has reinstated a Pennsylvania woman’s lawsuit alleging injuries caused by Zimmer Inc.’s Kinectiv Technology hip implant system with a VerSys femoral head, ruling that a jury must decide whether her claims are timely.
The Pennsylvania Supreme Court has reinstated two Risperdal actions against Janssen Pharmaceuticals Inc., ruling there are questions of fact as to whether the plaintiffs were on notice by October 2006 that their enlarged breasts were caused by the drug.
An Indiana federal judge has denied a Magnum hip plaintiff’s motion to compel Biomet Inc. to produce certain documents and information that the company has also provided the Plaintiffs’ Steering Committee, ruling that it would be duplicative.
A Maryland federal judge has consolidated four Biomet M2a Magnum Hip System cases for trial, concluding that there are common questions of fact and law in the cases, and consolidation will not prejudice Biomet.
A Maryland federal judge has dismissed an action involving an allegedly defective Medtronic left ventricular assistive device (LVAD), ruling that the claims are preempted because the plaintiffs failed to allege violations of state law requirements which parallel federal law.
Issue #144, November 2019
The judge presiding over the California coordinated Pradaxa docket has awarded Boehringer Ingelheim Pharmaceuticals Inc. summary judgment on a plaintiff’s inadequate warning claims, finding they are preempted by federal law.
Design defect and failure-to-warn claims asserted against the makers of generic ibuprofen are preempted by federal law, which prohibits the defendants from altering the drug or its label in any way, an Illinois federal judge has ruled.
A Mississippi federal judge has allowed claims of manufacturing defect and breach of express warranty to proceed against Apollo Endosurgery US Inc. in an intragastric balloon action, finding they are not preempted by federal law because they parallel federal requirements.
A California federal judge has dismissed a majority of the claims in a lawsuit targeting DJO Global Inc.’s walking boot, ruling that the plaintiff must identify which boot model he received, and the existence of a transaction between himself and the defendant manufacturer.
A Louisiana federal judge has awarded Ethicon Inc. summary judgment in a case involving its Proceed Ventral hernia repair patch, ruling that the plaintiff failed to present evidence of a feasible alternative design or that the patch’s construction deviated from design specifications.